Benefits of Melatonin 0.1 mg Tabs
Key Findings
0.1 mg melatonin has been shown to improve sleep parameters such as sleep duration and sleep efficiency in healthy adults, older adults with insomnia, and individuals with mental retardation and insomnia [1] [2] [3].
This dose can generate peak serum melatonin levels within the normal nocturnal range of untreated individuals [1].
While some studies indicate a modest hypothermic effect, higher doses (e.g., 1.0 mg to 5.0 mg) may be more consistent in producing a significant drop in core body temperature across subjects [4].
Introduction
Melatonin, a hormone primarily produced by the pineal gland, plays a crucial role in regulating the sleep-wake cycle and circadian rhythms. Exogenous melatonin supplementation is increasingly used to address various sleep disturbances and has shown potential benefits beyond sleep regulation. This report focuses on the benefits associated with a 0.1 mg dose of melatonin supplements.
Effects on Sleep Parameters
Oral administration of 0.1 mg melatonin has demonstrated hypnotic-like effects. A repeated-measure double-blind Latin square design study involving 20 healthy male volunteers found that 0.1 mg melatonin significantly increased sleep duration, self-reported sleepiness and fatigue, and decreased sleep-onset latency compared to placebo. This dose produced peak serum melatonin levels within the normal nocturnal range [1]. Similarly, a double-blind, placebo-controlled study in mentally retarded subjects (n = 20) with sleep deficits showed that 0.1 mg melatonin improved sleep [2]. Another double-blind, placebo-controlled study in insomniac subjects over 50 years old (n = 15) also reported improved sleep with 0.1 mg melatonin [3]. An umbrella review of meta-analyses based on randomized controlled trials found robust evidence for melatonin's improvement of sleep onset latency (standardized mean difference 0.33, 95% CI: 0.10 - 0.56, p < 0.01) in patients with sleep disorders [5]. A meta-analysis of 19 studies involving 1683 subjects confirmed that melatonin significantly reduced sleep latency (weighted mean difference 7.06 minutes, 95% CI 4.37 to 9.75, p<0.001) and increased total sleep time (weighted mean difference 8.25 minutes, 95% CI 1.74 to 14.75, p = 0.013), while also improving overall sleep quality (standardized mean difference 0.22, 95% CI: 0.12 to 0.32, p<0.001) [6].
Physiological and Other Effects
The 0.1 mg dose of melatonin can induce a hypothermic effect, reducing core body temperature, which may mediate its hypnotic action. In a study with 32 healthy adults, 0.1 mg melatonin caused a mean drop in core body temperature between 0.05 and 0.15 degrees C over 2 to 3 hours. However, doses between 1.0 mg and 5.0 mg were found to produce a more consistent drop in core body temperature across all subjects [4]. For children and adolescents, guidelines suggest that 0.1 mg can be sufficient for young children (under 12 years) for delayed sleep phase, with gradual increases up to 1.5 mg or 3 mg for adolescents [7]. Melatonin also has broader implications, including antioxidative, anti-inflammatory, and immunomodulatory properties, which may contribute to its emerging therapeutic potential in psychiatric disorders and neurodegenerative diseases [8] [9].
Conclusions
A 0.1 mg melatonin supplement can effectively improve sleep parameters such as sleep duration and sleep onset latency by achieving physiological serum melatonin levels. While it contributes to a modest reduction in core body temperature, higher doses may be more effective for consistent hypothermic effects. The benefits of melatonin extend beyond sleep, encompassing potential roles in cardiometabolic health, psychiatric disorders, and neurodegenerative diseases due to its antioxidant and anti-inflammatory properties.
References:
1) AB Dollins et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proceedings of the National Academy of Sciences of the United States of America (1994). https://pubmed.ncbi.nlm.nih.gov/8127888/
2) H Niederhofer et al. Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia. Journal of autism and developmental disorders (2003). https://pubmed.ncbi.nlm.nih.gov/12959427/
3) IV Zhdanova et al. Melatonin treatment for age-related insomnia. The Journal of clinical endocrinology and metabolism (2001). https://pubmed.ncbi.nlm.nih.gov/11600532/
4) D Dawson et al. The hypothermic effect of melatonin on core body temperature: is more better?. Journal of pineal research (1996). https://pubmed.ncbi.nlm.nih.gov/8836952/
5) S Lim et al. Effects of exogenous melatonin supplementation on health outcomes: An umbrella review of meta-analyses based on randomized controlled trials. Pharmacological research (2022). https://pubmed.ncbi.nlm.nih.gov/34999224/
6) E Ferracioli-Oda et al. Meta-analysis: melatonin for the treatment of primary sleep disorders. PloS one (2013). https://pubmed.ncbi.nlm.nih.gov/23691095/
7) Kenniscentrum KJP
8) HBC Le et al. The integrative role of melatonin in psychiatric disorders: A systematic review of evidence from circadian biology, lifestyle medicine, and psychoneuroimmunology. BioMedicine (2026). https://pubmed.ncbi.nlm.nih.gov/41523646/
9) NA Lashgari et al. Melatonin: Novel Insights in the Treatment of Neurodegenerative Diseases. Current medicinal chemistry (2026). https://pubmed.ncbi.nlm.nih.gov/41755415/